Gliclazide improves anti-oxidant status and nitric oxide-mediated vasodilation in Type 2 diabetes. (Q44122840)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12207812%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Gliclazide improves anti-oxidant status and nitric oxide-mediated vasodilation in Type 2 diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12207812%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12207812%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

D Fava

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12207812%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M Cassone-Faldetta

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12207812%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

O Laurenti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12207812%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

O De Luca

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12207812%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

G De Mattia

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12207812%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

1 reference

1 September 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12207812%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12207812%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12207812%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12207812%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

752-757

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12207812%20AND%20SRC:MED&resulttype=core&format=json

Free radicals in diabetic endothelial cell dysfunction

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00762.X

Oxidative stress and diabetic vascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00762.X

Nitric oxide availability in diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00762.X

Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00762.X

Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00762.X

Gliclazide: a general free radical scavenger

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00762.X

Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00762.X

In vitro and in vivo antioxidant properties of gliclazide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00762.X

Metformin improves hemodynamic and rheological responses to L-arginine in NIDDM patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00762.X

Total radical-trapping antioxidant parameter in NIDDM patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00762.X

L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00762.X

Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00762.X

The vascular effects of L-Arginine in humans. The role of endogenous insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00762.X

A fluorescence-based method for measuring total plasma antioxidant capability

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00762.X

10.1046/J.1464-5491.2002.00762.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12207812%20AND%20SRC:MED&resulttype=core&format=json

release_3bcn62t25jcczafdelyvih6tgy

12 November 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3bcn62t25jcczafdelyvih6tgy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference